Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Olanzapine/risperidone

Olanzapine/risperidone Reactions 1680, p267 - 2 Dec 2017 Extrapyramidal side effects: case report A 48-year-old man developed extrapyramidal side effects during treatment with olanzapine and risperidone. The man had a history of bilateral otitis media and had undergone bilateral myringoplasty at the age of 18 years. At the age of 38 years, he presented with psychiatric symptoms, for which he received risperidone. Following 9.5 years of this treatment, his symptoms worsened for several times due to the discontinuation of treatment. However, after commencing individual treatment with olanzapine 20mg and risperidone 8mg for three weeks each [route not stated], the symptoms persisted. He developed extrapyramidal side effects [duration of treatment to reaction onset and outcome not stated]. The man’s antipsychotic therapy was switched to trifluoperazine and he received trihexyphenidyl to manage extrapyramidal side effects. Author comment: ’’Despite individual treatment with risperidone 8 mg and olanzapine 20 mg for 3weeks each, the symptoms did not improve. However, within 2 weeks of switching to trifluoperazine 30 mg and trihexyphenidyl 4–6 mg (to manage extrapyramidal side effects), his psychotic symptoms improved completely’’. Jain S, et al. Improvement of tinnitus with trifluoperazine in a patient with psychosis and ear disease. Asian Journal of Psychiatry 30: http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Olanzapine/risperidone

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017

Olanzapine/risperidone

Abstract

Reactions 1680, p267 - 2 Dec 2017 Extrapyramidal side effects: case report A 48-year-old man developed extrapyramidal side effects during treatment with olanzapine and risperidone. The man had a history of bilateral otitis media and had undergone bilateral myringoplasty at the age of 18 years. At the age of 38 years, he presented with psychiatric symptoms, for which he received risperidone. Following 9.5 years of this treatment, his symptoms worsened for several times due to the...
Loading next page...
1
 
/lp/springer_journal/olanzapine-risperidone-uyCAYngB4B

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-017-39198-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p267 - 2 Dec 2017 Extrapyramidal side effects: case report A 48-year-old man developed extrapyramidal side effects during treatment with olanzapine and risperidone. The man had a history of bilateral otitis media and had undergone bilateral myringoplasty at the age of 18 years. At the age of 38 years, he presented with psychiatric symptoms, for which he received risperidone. Following 9.5 years of this treatment, his symptoms worsened for several times due to the discontinuation of treatment. However, after commencing individual treatment with olanzapine 20mg and risperidone 8mg for three weeks each [route not stated], the symptoms persisted. He developed extrapyramidal side effects [duration of treatment to reaction onset and outcome not stated]. The man’s antipsychotic therapy was switched to trifluoperazine and he received trihexyphenidyl to manage extrapyramidal side effects. Author comment: ’’Despite individual treatment with risperidone 8 mg and olanzapine 20 mg for 3weeks each, the symptoms did not improve. However, within 2 weeks of switching to trifluoperazine 30 mg and trihexyphenidyl 4–6 mg (to manage extrapyramidal side effects), his psychotic symptoms improved completely’’. Jain S, et al. Improvement of tinnitus with trifluoperazine in a patient with psychosis and ear disease. Asian Journal of Psychiatry 30:

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

There are no references for this article.